… effects of dapagliflozin versus placebo on KCCQ-CSS at 12 weeks specifically in patients with
EF of ≥65%. The effects of dapagliflozin … test whether these effects of dapagliflozin versus …

… but has not routinely been applied in heart failure. In part, this … of Adverse-Outcomes in Heart
Failure), the sodium-glucose … worsening heart failure (HF) in patients with heart failure and …

… Although a post hoc analysis indicated the effects of dapagliflozin were independent of
sacubitril-valsartan use, further evaluation of the interaction between dapagliflozin and sacubitril-…

… death), the composite of hospitalization for heart failure or cardiovascular death, and all-cause …
Here, we report the effects of dapagliflozin on the prespecified kidney and cardiovascular …

… In this paper, we discuss recently published findings on the effects of dapagliflozin on the
incidence of VA, cardiac arrest, and sudden death, explaining how these could influence …

… A recent RCT looked at the effects of dapagliflozin on exercise capacity in 90 stable patients
… Outcomes in Heart Failure (DAPA-HF) trial to examine the effects of dapagliflozin on …

… The effects of dapagliflozin on eGFR, body weight, SBP, and hematocrit were directionally
similar in Black and White patients. In this respect, it is worth noting that the blood pressure …

… Dapagliflozin reduced the risk of worsening heart failure events and death, and improved …
(A) Effects of dapagliflozin compared with placebo on clinical outcomes according AF status …

… The present study has multiple strengths, most notably its focus on the effects of dapagliflozin
on 6MWT distance in an appropriately powered randomized clinical trial, the inclusion of …

… With Heart Failure) trial comprised 2 randomized, placebo-controlled trials of heart failure—…
with HFpEF—which investigated the effects of dapagliflozin on KCCQ Total Symptom Score …